{
  "_originalData": {
    "identity": {
      "bacteriumName": "Ehrlichia and Anaplasma species",
      "aliases": [
        "Ehrlichiosis",
        "Anaplasmosis",
        "Human Monocytotropic Ehrlichiosis (HME)",
        "Human Granulocytotropic Anaplasmosis (HGA)"
      ],
      "lastUpdated": "2023-08-07",
      "clsiCategory": "Not classified by CLSI",
      "classification": {
        "gramStain": "Gram-negative",
        "morphology": "Coccobacillus",
        "respiration": "Aerobic",
        "notes": [
          "Obligate intracellular bacteria"
        ]
      },
      "strainDetails": [
        {
          "type": "Species",
          "value": "Ehrlichia chaffeensis",
          "notes": "Causes Human Monocytotropic Ehrlichiosis (HME). Transmitted by the Lone Star tick."
        },
        {
          "type": "Species",
          "value": "Anaplasma phagocytophilum",
          "notes": "Causes Human Granulocytotropic Anaplasmosis (HGA). Transmitted by Ixodes ticks."
        },
        {
          "type": "Species",
          "value": "Ehrlichia ewingii",
          "notes": "Causes a form of ehrlichiosis similar to HGA. Transmitted by the Lone Star tick."
        }
      ],
      "biochemicalTests": "Obligate intracellular Gram-negative bacteria. Do not grow on artificial media. Diagnosis is by identifying morulae within leukocytes on a peripheral blood smear (Giemsa stain), serology, or PCR."
    },
    "clinicalProfile": {
      "summary": "Ehrlichiosis and anaplasmosis are tick-borne illnesses caused by obligate intracellular bacteria that infect white blood cells. The initial presentation is typically a non-specific febrile illness with headache and myalgia. Co-infection with other tick-borne pathogens like Borrelia and Babesia should always be considered.",
      "pathophysiologyPearls": [
        "These bacteria multiply within the cytoplasm of leukocytes (monocytes for E. chaffeensis, granulocytes for A. phagocytophilum and E. ewingii), forming characteristic microcolonies called morulae.",
        "Infection leads to a systemic inflammatory response, causing fever and other constitutional symptoms."
      ],
      "keySignsAndSymptoms": [
        "Fever",
        "Headache",
        "Myalgia",
        "Nausea, vomiting",
        "Rash (more common in HME, especially in children)",
        "Thrombocytopenia",
        "Leukopenia",
        "Elevated liver transaminases (AST, ALT)"
      ],
      "clinicalSyndromes": [
        {
          "syndromeName": "Human Monocytotropic Ehrlichiosis (HME)",
          "description": "Caused by E. chaffeensis. Rash is present in about 23% of adults and 60% of children."
        },
        {
          "syndromeName": "Human Granulocytotropic Anaplasmosis (HGA)",
          "description": "Caused by A. phagocytophilum. Rash is rare."
        },
        {
          "syndromeName": "Ewingii Ehrlichiosis",
          "description": "Caused by E. ewingii. Clinically similar to HGA."
        }
      ],
      "highRiskPopulations": [
        "Individuals with exposure to tick-infested areas, particularly in the central, southern, and mid-Atlantic US (Lone Star tick) and New England, north-central, and Pacific US (Ixodes tick)."
      ],
      "transmissionVectors": [
        "Ticks (Lone Star tick for Ehrlichia, Ixodes tick for Anaplasma)"
      ],
      "prognosisNotes": [
        "Early treatment with doxycycline is highly effective. Delay in therapy can lead to severe illness, including meningoencephalitis, ARDS, and death."
      ]
    },
    "resistanceProfile": {
      "groupIntrinsicResistance": [],
      "intrinsicResistance": [
        {
          "drugOrClass": "Clindamycin",
          "notes": "Resistant"
        },
        {
          "drugOrClass": "TMP-SMX",
          "notes": "Resistant"
        },
        {
          "drugOrClass": "Imipenem-cilastatin",
          "notes": "Resistant"
        },
        {
          "drugOrClass": "Ampicillin",
          "notes": "Resistant"
        },
        {
          "drugOrClass": "Erythromycin",
          "notes": "Resistant"
        },
        {
          "drugOrClass": "Azithromycin",
          "notes": "Resistant"
        }
      ],
      "majorMechanisms": [],
      "clinicalAlerts": []
    },
    "treatment": {
      "generalNotes": [
        "Specific therapy should not be delayed pending laboratory confirmation in suspected cases."
      ],
      "drugsToAvoid": [],
      "adjunctiveTherapies": [],
      "regimens": [
        {
          "context": {
            "type": "Empiric/Directed",
            "condition": "Ehrlichiosis/Anaplasmosis",
            "patientPopulation": [
              "Adults"
            ],
            "isolateSource": null
          },
          "recommendations": [
            {
              "preference": "Primary",
              "strategy": "Monotherapy",
              "steps": [
                {
                  "step": 1,
                  "duration": "10 days",
                  "drugs": [
                    {
                      "drugName": "Doxycycline",
                      "dose": "100 mg",
                      "route": "IV/PO",
                      "frequency": "BID",
                      "comments": ""
                    }
                  ]
                }
              ],
              "notes": []
            }
          ]
        },
        {
          "context": {
            "type": "Empiric/Directed",
            "condition": "Ehrlichiosis/Anaplasmosis",
            "patientPopulation": [
              "Children < 45 kg"
            ],
            "isolateSource": null
          },
          "recommendations": [
            {
              "preference": "Primary",
              "strategy": "Monotherapy",
              "steps": [
                {
                  "step": 1,
                  "duration": "10 days",
                  "drugs": [
                    {
                      "drugName": "Doxycycline",
                      "dose": "2.2 mg/kg",
                      "route": "IV/PO",
                      "frequency": "BID",
                      "comments": "Max dose 100 mg"
                    }
                  ]
                }
              ],
              "notes": []
            }
          ]
        },
        {
          "context": {
            "type": "Empiric/Directed",
            "condition": "Ehrlichiosis/Anaplasmosis in Pregnancy",
            "patientPopulation": [
              "Pregnant women"
            ],
            "isolateSource": null
          },
          "recommendations": [
            {
              "preference": "Primary",
              "strategy": "Monotherapy",
              "steps": [
                {
                  "step": 1,
                  "duration": "10 days",
                  "drugs": [
                    {
                      "drugName": "Rifampin",
                      "dose": "10 mg/kg (max 300 mg)",
                      "route": "PO",
                      "frequency": "BID",
                      "comments": "Doxycycline is generally avoided but may be warranted in life-threatening infections."
                    }
                  ]
                }
              ],
              "notes": []
            }
          ]
        }
      ]
    },
    "laboratoryProfile": {
      "testingIndications": [
        "Febrile illness after a tick bite or exposure to tick-endemic areas.",
        "Unexplained fever with thrombocytopenia, leukopenia, and elevated transaminases."
      ],
      "methodologyNotes": [
        "PCR is the preferred diagnostic method in the acute phase of illness."
      ],
      "recommendedPanel": [],
      "specialTests": [
        {
          "testName": "PCR",
          "trigger": "Acute febrile illness with tick exposure",
          "purpose": "To detect Ehrlichia or Anaplasma DNA in whole blood. Most sensitive method during the first week of illness."
        },
        {
          "testName": "Indirect Fluorescent Antibody (IFA) Assay",
          "trigger": "Suspicion of ehrlichiosis/anaplasmosis",
          "purpose": "To detect antibodies. A four-fold rise in titer between acute and convalescent samples is diagnostic. Requires species-specific assays."
        },
        {
          "testName": "Peripheral Blood Smear",
          "trigger": "Acute febrile illness with tick exposure",
          "purpose": "To look for intracytoplasmic morulae in leukocytes. More likely to be positive in HGA (20-80%) than HME (1-20%)."
        }
      ],
      "reportingRules": [],
      "antimicrobialBreakpoints": []
    },
    "additionalInformation": {
      "diagnosticNotes": {
        "summary": "Diagnosis is based on a combination of clinical findings, epidemiological risk, and laboratory tests (PCR, serology, blood smear). Treatment should not be delayed for laboratory confirmation.",
        "biosafetyWarning": "Standard precautions are sufficient for handling clinical specimens.",
        "methods": []
      },
      "preventionAndScreening": [
        {
          "type": "Prevention",
          "details": "Avoiding tick bites through personal protective measures (e.g., repellents, protective clothing) and prompt tick removal.",
          "targetPopulation": "General population in endemic areas."
        }
      ],
      "treatmentLifecycle": [],
      "antimicrobialStewardship": [],
      "drugSpecificPearls": [],
      "guidelineReferences": [
        {
          "source": "JAMA",
          "citation": "315:1767, 2016",
          "summaryOrNote": "Review of tick-borne diseases."
        },
        {
          "source": "Clinical Chemistry",
          "citation": "2020; 66:537",
          "summaryOrNote": "Summary of laboratory methods for diagnosing tick-borne diseases in the USA."
        }
      ]
    }
  },
  "_metadata": {
    "originalKeys": [
      "identity",
      "clinicalProfile",
      "resistanceProfile",
      "treatment",
      "laboratoryProfile",
      "additionalInformation"
    ],
    "conversionTimestamp": "2025-07-15T03:16:49.376Z",
    "sourceFormat": "modern"
  },
  "identity": {
    "bacteriumName": {
      "sources": [
        "identity.bacteriumName"
      ],
      "value": "Ehrlichia and Anaplasma species"
    },
    "aliases": {
      "sources": [
        "identity.aliases"
      ],
      "value": [
        "Ehrlichiosis",
        "Anaplasmosis",
        "Human Monocytotropic Ehrlichiosis (HME)",
        "Human Granulocytotropic Anaplasmosis (HGA)"
      ]
    },
    "lastUpdated": {
      "sources": [
        "identity.lastUpdated"
      ],
      "value": "2023-08-07"
    },
    "classification": {
      "sources": [
        "identity.classification"
      ],
      "value": {
        "gramStain": "Gram-negative",
        "morphology": "Coccobacillus",
        "respiration": "Aerobic",
        "notes": [
          "Obligate intracellular bacteria"
        ]
      }
    }
  },
  "clinicalInformation": {
    "sources": [
      "clinicalProfile"
    ],
    "value": {
      "summary": "Ehrlichiosis and anaplasmosis are tick-borne illnesses caused by obligate intracellular bacteria that infect white blood cells. The initial presentation is typically a non-specific febrile illness with headache and myalgia. Co-infection with other tick-borne pathogens like Borrelia and Babesia should always be considered.",
      "pathophysiologyPearls": [
        "These bacteria multiply within the cytoplasm of leukocytes (monocytes for E. chaffeensis, granulocytes for A. phagocytophilum and E. ewingii), forming characteristic microcolonies called morulae.",
        "Infection leads to a systemic inflammatory response, causing fever and other constitutional symptoms."
      ],
      "keySignsAndSymptoms": [
        "Fever",
        "Headache",
        "Myalgia",
        "Nausea, vomiting",
        "Rash (more common in HME, especially in children)",
        "Thrombocytopenia",
        "Leukopenia",
        "Elevated liver transaminases (AST, ALT)"
      ],
      "clinicalSyndromes": [
        {
          "syndromeName": "Human Monocytotropic Ehrlichiosis (HME)",
          "description": "Caused by E. chaffeensis. Rash is present in about 23% of adults and 60% of children."
        },
        {
          "syndromeName": "Human Granulocytotropic Anaplasmosis (HGA)",
          "description": "Caused by A. phagocytophilum. Rash is rare."
        },
        {
          "syndromeName": "Ewingii Ehrlichiosis",
          "description": "Caused by E. ewingii. Clinically similar to HGA."
        }
      ],
      "highRiskPopulations": [
        "Individuals with exposure to tick-infested areas, particularly in the central, southern, and mid-Atlantic US (Lone Star tick) and New England, north-central, and Pacific US (Ixodes tick)."
      ],
      "transmissionVectors": [
        "Ticks (Lone Star tick for Ehrlichia, Ixodes tick for Anaplasma)"
      ],
      "prognosisNotes": [
        "Early treatment with doxycycline is highly effective. Delay in therapy can lead to severe illness, including meningoencephalitis, ARDS, and death."
      ]
    }
  },
  "resistanceInformation": {
    "sources": [
      "resistanceProfile"
    ],
    "value": {
      "groupIntrinsicResistance": [],
      "intrinsicResistance": [
        {
          "drugOrClass": "Clindamycin",
          "notes": "Resistant"
        },
        {
          "drugOrClass": "TMP-SMX",
          "notes": "Resistant"
        },
        {
          "drugOrClass": "Imipenem-cilastatin",
          "notes": "Resistant"
        },
        {
          "drugOrClass": "Ampicillin",
          "notes": "Resistant"
        },
        {
          "drugOrClass": "Erythromycin",
          "notes": "Resistant"
        },
        {
          "drugOrClass": "Azithromycin",
          "notes": "Resistant"
        }
      ],
      "majorMechanisms": [],
      "clinicalAlerts": []
    }
  },
  "treatmentData": {
    "treatmentData": {
      "_treatmentMetadata": {
        "originalFormat": "modern"
      },
      "standardizedRegimens": [
        {
          "regimenId": "modern-0-0-0",
          "extractedFrom": "treatment.regimens[0].recommendations[0].steps[0]",
          "context": {
            "type": "empiric/directed",
            "condition": "Ehrlichiosis/Anaplasmosis",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "Adults"
              ],
              "labFindings": null
            }
          },
          "preference": "primary",
          "drugs": [
            {
              "drugName": "Doxycycline",
              "dose": "100 mg",
              "route": "IV/PO",
              "frequency": "BID",
              "duration": "10 days",
              "comments": "",
              "originalText": "Doxycycline 100 mg IV/PO BID"
            }
          ]
        },
        {
          "regimenId": "modern-1-0-0",
          "extractedFrom": "treatment.regimens[1].recommendations[0].steps[0]",
          "context": {
            "type": "empiric/directed",
            "condition": "Ehrlichiosis/Anaplasmosis",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "Children < 45 kg"
              ],
              "labFindings": null
            }
          },
          "preference": "primary",
          "drugs": [
            {
              "drugName": "Doxycycline",
              "dose": "2.2 mg/kg",
              "route": "IV/PO",
              "frequency": "BID",
              "duration": "10 days",
              "comments": "Max dose 100 mg",
              "originalText": "Doxycycline 2.2 mg/kg IV/PO BID"
            }
          ]
        },
        {
          "regimenId": "modern-2-0-0",
          "extractedFrom": "treatment.regimens[2].recommendations[0].steps[0]",
          "context": {
            "type": "empiric/directed",
            "condition": "Ehrlichiosis/Anaplasmosis in Pregnancy",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "Pregnant women"
              ],
              "labFindings": null
            }
          },
          "preference": "primary",
          "drugs": [
            {
              "drugName": "Rifampin",
              "dose": "10 mg/kg (max 300 mg)",
              "route": "PO",
              "frequency": "BID",
              "duration": "10 days",
              "comments": "Doxycycline is generally avoided but may be warranted in life-threatening infections.",
              "originalText": "Rifampin 10 mg/kg (max 300 mg) PO BID"
            }
          ]
        }
      ]
    }
  },
  "laboratoryData": {
    "sources": [
      "laboratoryProfile"
    ],
    "value": {
      "testingIndications": [
        "Febrile illness after a tick bite or exposure to tick-endemic areas.",
        "Unexplained fever with thrombocytopenia, leukopenia, and elevated transaminases."
      ],
      "methodologyNotes": [
        "PCR is the preferred diagnostic method in the acute phase of illness."
      ],
      "recommendedPanel": [],
      "specialTests": [
        {
          "testName": "PCR",
          "trigger": "Acute febrile illness with tick exposure",
          "purpose": "To detect Ehrlichia or Anaplasma DNA in whole blood. Most sensitive method during the first week of illness."
        },
        {
          "testName": "Indirect Fluorescent Antibody (IFA) Assay",
          "trigger": "Suspicion of ehrlichiosis/anaplasmosis",
          "purpose": "To detect antibodies. A four-fold rise in titer between acute and convalescent samples is diagnostic. Requires species-specific assays."
        },
        {
          "testName": "Peripheral Blood Smear",
          "trigger": "Acute febrile illness with tick exposure",
          "purpose": "To look for intracytoplasmic morulae in leukocytes. More likely to be positive in HGA (20-80%) than HME (1-20%)."
        }
      ],
      "reportingRules": [],
      "antimicrobialBreakpoints": []
    }
  },
  "additionalData": {
    "antimicrobialStewardship": {
      "sources": [
        "antimicrobial_stewardship",
        "antimicrobialStewardship"
      ],
      "value": []
    },
    "comments": {
      "preservedStructure": {
        "originalFormat": "object"
      }
    },
    "diagnosis": {
      "sources": [
        "diagnosis"
      ],
      "value": []
    },
    "allOtherKeys": {}
  }
}